These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8485626

  • 1. Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus.
    Corsi M, Pojani G, Dal Forno G, Pietra C, Gaviraghi G, Trist D.
    Br J Pharmacol; 1993 Apr; 108(4):1164-8. PubMed ID: 8485626
    [Abstract] [Full Text] [Related]

  • 2. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [Abstract] [Full Text] [Related]

  • 3. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
    Dal Forno G, Pietra C, Urciuoli M, van Amsterdam FT, Toson G, Gaviraghi G, Trist D.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
    [Abstract] [Full Text] [Related]

  • 4. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
    Schutte IW, Akkermans LM, Kroese AB.
    J Auton Nerv Syst; 1997 Dec 03; 67(1-2):51-9. PubMed ID: 9470144
    [Abstract] [Full Text] [Related]

  • 5. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 03; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 6. Combined dose-ratio analysis for the CCK-B antagonist virginiamycin in guinea pig ileum.
    Corsi M, Dal Forno G, Oliosi B, Pietra C, van Amsterdam FT, Trist DG.
    Ann N Y Acad Sci; 1994 Mar 23; 713():353-4. PubMed ID: 8185185
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum.
    Patel M, Spraggs CF.
    Br J Pharmacol; 1992 Jun 23; 106(2):275-82. PubMed ID: 1393262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX.
    Zhongguo Yao Li Xue Bao; 1993 Sep 23; 14(5):443-6. PubMed ID: 8010038
    [Abstract] [Full Text] [Related]

  • 12. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
    Lucaites VL, Mendelsohn LG, Mason NR, Cohen ML.
    J Pharmacol Exp Ther; 1991 Feb 23; 256(2):695-703. PubMed ID: 1704435
    [Abstract] [Full Text] [Related]

  • 13. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May 23; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H, Yazaki N, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 May 23; 304(1-3):147-54. PubMed ID: 8813597
    [Abstract] [Full Text] [Related]

  • 15. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M, Stamford IF, Bennett A.
    Br J Pharmacol; 1991 Feb 23; 102(2):391-5. PubMed ID: 2015421
    [Abstract] [Full Text] [Related]

  • 16. Functional evidence for the involvement of GABAA receptors in cholecystokinin-induced ileal contraction.
    Alican I, Yeğen BC, Oktay S, Ulusoy NB.
    Can J Physiol Pharmacol; 1995 Nov 23; 73(11):1596-9. PubMed ID: 8789413
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    Ballaz S, Barber A, Fortuño A, Del Río J, Martin-Martínez M, Gómez-Monterrey I, Herranz R, González-Muñiz R, García-López MT.
    Br J Pharmacol; 1997 Jun 23; 121(4):759-67. PubMed ID: 9208145
    [Abstract] [Full Text] [Related]

  • 18. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 23; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P, Böhme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE.
    Eur J Pharmacol; 1994 Sep 12; 262(3):233-45. PubMed ID: 7813588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.